tiprankstipranks
Trending News
More News >
Arcturus Therapeutics (ARCT)
NASDAQ:ARCT
US Market

Arcturus Therapeutics (ARCT) Income Statement

Compare
2,152 Followers

Arcturus Therapeutics Income Statement

Last quarter (Q4 2025), Arcturus Therapeutics's total revenue was $3.08M, a decrease of -85.33% from the same quarter last year. In Q4, Arcturus Therapeutics's net income was $-29.08M. See Arcturus Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 67.22M$ 138.39M$ 157.75M$ 205.75M$ 12.36M
Gross Profit
$ 64.20M$ 138.39M$ 157.75M$ 205.75M$ 12.36M
Operating Expenses
$ 139.15M$ 234.06M$ 235.95M$ 193.58M$ 215.21M
Depreciation and Amortization
$ 3.02M$ 3.54M$ 2.96M$ 1.53M$ 1.19M
EBITDA
$ -71.93M$ -77.40M$ -24.16M$ 13.70M$ -201.66M
Operating Income
$ -74.95M$ -95.67M$ -78.20M$ 12.18M$ -202.85M
Other Income/Expenses
$ 9.17M$ 14.72M$ 50.31M$ -1.53M$ -822.00K
Pretax Income
$ -65.78M$ -80.94M$ -27.89M$ 10.64M$ -203.67M
Net Income
$ -65.78M$ -80.94M$ -29.73M$ 9.35M$ -203.67M
Per Share Metrics
Basic EPS
$ -2.40$ -3.00$ -1.12$ 0.35$ -7.74
Diluted EPS
$ -2.40$ -3.00$ -1.12$ 0.35$ -7.74
Weighted Average Shares Outstanding
27.39M 27.00M 26.63M 26.45M 26.32M
Weighted Average Shares Outstanding (Diluted)
27.39M 27.00M 26.63M 27.09M 26.32M
Currency in USD

Arcturus Therapeutics Earnings and Revenue History